A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.

PLoS One · 2007 · PMC2001290 · PMID 17925866

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

borderline significantp = 0.09so close (0.05 < p ≤ 0.1)

When comparing response indices after the first to the ones after the second immunization in the PEV301 50 μg groups, the difference was borderline significant (p = 0.09) indicating that the initial response was possibly boosted by the second administration.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.